~~<i id='97C3E0F694'><strike id='97C3E0F694'><tt id='97C3E0F694'><pre id='97C3E0F694'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：comprehensive 2025-09-28 00:00:18 Page View：68

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Diversity in clinical trials starts with building trust, experts say
Next article： Psychedelics group wrestles with new pharma identity

comprehensive

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Health care needs a new profession: neuroimaging counseling

AnMRIscanimageofabrainALAINJOCARD/AFPviaGettyImagesUntilrecently,gettinganMRImeanttravelingtothehosp

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Cano Health’s bankruptcy is a warning for Medicare Advantage

AdobePrivateMedicarejustisn’tthegoldmineitoncewas.Caseinpoint:CanoHealth,acompanyoncevaluedat$4.4bil